These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 35887878)
1. Impact of Cryopreservation of Peripheral Blood Stem Cells (PBSC) in Transplantation from Matched Unrelated Donor (MUD). Facchin G; Savignano C; Battista ML; Isola M; De Martino M; Petruzzellis G; Rosignoli C; Pizzano U; Cerno M; De Cecco G; Bertone A; Barillari G; Fanin R; Patriarca F J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887878 [TBL] [Abstract][Full Text] [Related]
2. CD34+ Stem Cell Selection and CD3+ T Cell Add-Back from Matched Unrelated Adult Donors in Children with Primary Immunodeficiencies and Hematological Diseases. Porta F; Comini M; Soncini E; Carracchia G; Maffeis M; Pintabona V; Bolda F; Beghin A; Schumacher RF; Lanfranchi A Transplant Cell Ther; 2021 May; 27(5):426.e1-426.e9. PubMed ID: 33965183 [TBL] [Abstract][Full Text] [Related]
3. Universal Engraftment after Allogeneic Hematopoietic Cell Transplantation Using Cryopreserved CD34-Selected Grafts. Jacob RP; Flynn J; Devlin SM; Maloy M; Giralt SA; Maslak P; O'Reilly RJ; Tonon JA; Perales MA; Avecilla ST; Cho C Transplant Cell Ther; 2021 Aug; 27(8):697.e1-697.e5. PubMed ID: 33991721 [TBL] [Abstract][Full Text] [Related]
4. A French single-center experience on allogeneic stem cell transplant cryopreservation during severe acute respiratory syndrome coronavirus 2 pandemic. Laroye C; Thilly N; Gauthier M; Luc A; Latger-Cannard V; Eschwege V; Bensoussan D; Pochon C; Campidelli A; Rubio MT; D'Aveni M; Decot V Cytotherapy; 2023 Aug; 25(8):877-884. PubMed ID: 37178096 [TBL] [Abstract][Full Text] [Related]
5. The Impact of Cryopreservation on Hematopoietic Stem Cell Engraftment and Post-transplant Outcome During the COVID-19 Pandemic. Strzelec A; Gawlik-Rzemieniewska N; Klima A; Panek K; Helbig G In Vivo; 2024; 38(3):1271-1277. PubMed ID: 38688614 [TBL] [Abstract][Full Text] [Related]
6. Cryopreservation of allogeneic PBSC from related and unrelated donors is associated with delayed platelet engraftment but has no impact on survival. Medd P; Nagra S; Hollyman D; Craddock C; Malladi R Bone Marrow Transplant; 2013 Feb; 48(2):243-8. PubMed ID: 22732701 [TBL] [Abstract][Full Text] [Related]
7. Outcome of Haploidentical Peripheral Blood Allografts Using Post-Transplantation Cyclophosphamide Compared to Matched Sibling and Unrelated Donor Bone Marrow Allografts in Pediatric Patients with Hematologic Malignancies: A Single-Center Analysis. Srinivasan A; Raffa E; Wall DA; Schechter T; Ali M; Chopra Y; Kung R; Chiang KY; Krueger J Transplant Cell Ther; 2022 Mar; 28(3):158.e1-158.e9. PubMed ID: 34838785 [TBL] [Abstract][Full Text] [Related]
8. Outcomes with allogeneic stem cell transplant using cryopreserved versus fresh hematopoietic progenitor cell products. Wan BA; Lindo L; Mourad YA; Chung S; Forrest D; Kuchenbauer F; Nantel S; Narayanan S; Nevill T; Power M; Rodrigo J; Sanford D; Song K; Stubbins RJ; Sutherland H; Toze CL; White J; Roy C; Hay KA Cytotherapy; 2024 Oct; 26(10):1210-1216. PubMed ID: 38819367 [TBL] [Abstract][Full Text] [Related]
9. Addition of Anti-thymocyte Globulin in Allogeneic Stem Cell Transplantation With Peripheral Stem Cells From Matched Unrelated Donors Improves Graft-Versus-Host Disease and Relapse Free Survival. Ali MM; Grønvold B; Remberger M; Abrahamsen IW; Myhre AE; Tjønnfjord GE; Fløisand Y; Gedde-Dahl T Clin Lymphoma Myeloma Leuk; 2021 Sep; 21(9):598-605. PubMed ID: 34158268 [TBL] [Abstract][Full Text] [Related]
10. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Körbling M; Przepiorka D; Huh YO; Engel H; van Besien K; Giralt S; Andersson B; Kleine HD; Seong D; Deisseroth AB Blood; 1995 Mar; 85(6):1659-65. PubMed ID: 7888684 [TBL] [Abstract][Full Text] [Related]
13. The Effect of Donor Graft Cryopreservation on Allogeneic Hematopoietic Cell Transplantation Outcomes: A Center for International Blood and Marrow Transplant Research Analysis. Implications during the COVID-19 Pandemic. Hsu JW; Farhadfar N; Murthy H; Logan BR; Bo-Subait S; Frey N; Goldstein SC; Horowitz MM; Lazarus H; Schwanke JD; Shah NN; Spellman SR; Switzer GE; Devine SM; Shaw BE; Wingard JR Transplant Cell Ther; 2021 Jun; 27(6):507-516. PubMed ID: 33865804 [TBL] [Abstract][Full Text] [Related]
14. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia]. Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851 [TBL] [Abstract][Full Text] [Related]
16. Post-Transplantation Cyclophosphamide for Graft-versus- Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison by Donor Type. A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation. Sahebi F; Eikema DJ; Koster L; Kroger N; Meijer E; van Doesum JA; Rovira M; Koc Y; Angelucci E; Blaise D; Sammassimo S; McDonald A; Arroyo CH; Sanchez JF; Forcade E; Castagna L; Stölzel F; Sanz J; Tischer J; Ciceri F; Valcarcel D; Proia A; Hayden PJ; Beksac M; Yakoub-Agha I; Schönland S Transplant Cell Ther; 2021 Dec; 27(12):999.e1-999.e10. PubMed ID: 34543768 [TBL] [Abstract][Full Text] [Related]
17. Cryopreservation of Unrelated Hematopoietic Stem Cells from a Blood and Marrow Donor Bank During the COVID-19 Pandemic: A Nationwide Survey by the Japan Marrow Donor Program. Kanda Y; Inoue M; Uchida N; Onishi Y; Kamata R; Kotaki M; Kobayashi R; Tanaka J; Fukuda T; Fujii N; Miyamura K; Mori SI; Mori Y; Morishima Y; Yabe H; Kodera Y Transplant Cell Ther; 2021 Aug; 27(8):664.e1-664.e6. PubMed ID: 33964514 [TBL] [Abstract][Full Text] [Related]
18. Post-Transplantation Cyclophosphamide-Based Haploidentical versus Matched Unrelated Donor Peripheral Blood Hematopoietic Stem Cell Transplantation Using Myeloablative Targeted Busulfan-Based Conditioning for Pediatric Acute Leukemia. Hong KT; Park HJ; Kim BK; An HY; Choi JY; Kang HJ Transplant Cell Ther; 2022 Apr; 28(4):195.e1-195.e7. PubMed ID: 35021131 [TBL] [Abstract][Full Text] [Related]
19. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia. Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100 [TBL] [Abstract][Full Text] [Related]
20. The effect of cryopreservation on engraftment kinetics in fully matched allogeneic stem cell transplantation: Real-life data and literature review. Ersal T; Özkocaman V; Yalçın C; Orhan B; Candar Ö; Çubukçu S; Koca TG; Pınar İE; Hunutlu FÇ; Özkalemkaş F Transfus Apher Sci; 2023 Dec; 62(6):103821. PubMed ID: 37775358 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]